Most linked-to pages

Showing below up to 50 results in range #901 to #950.

901. Reference:USA 21 CFR Part 54 09-Apr-2025 § 54.4 disclosure (6 links)
902. Reference:USA 21 CFR Part 54 09-Apr-2025 § 54.4 list of investigators (6 links)
903. Reference:USA 21 CFR Part 56 09-Apr-2025 § 56.103 (6 links)
904. Reference:USA 21 CFR Part 56 09-Apr-2025 § 56.113-001 (6 links)
905. Reference:USA 21 CFR Part 56 09-Apr-2025 § 56.113-002 (6 links)
906. Reference:USA 21 CFR Part 812 09-Apr-2025 Subpart B (6 links)
907. Reference:USA 21 CFR Part 812 09-Apr-2025 Subpart D (6 links)
908. Reference:USA 21 CFR Part 812 09-Apr-2025 Subpart E (6 links)
909. Reference:USA 21 CFR Part 812 09-Apr-2025 § 812.110 (c) (6 links)
910. Reference:USA 21 CFR Part 812 09-Apr-2025 § 812.119 (6 links)
911. Reference:USA 21 CFR Part 812 09-Apr-2025 § 812.140 (e) (6 links)
912. Reference:USA 21 CFR Part 812 09-Apr-2025 § 812.150 (a) (6) (6 links)
913. Reference:USA 21 CFR Part 812 09-Apr-2025 § 812.27 (6 links)
914. Reference:USA 21 CFR Part 812 09-Apr-2025 § 812.30 (6 links)
915. Reference:USA 21 CFR Part 812 09-Apr-2025 § 812.30 (b) - (c) (6 links)
916. Reference:USA 21 CFR Part 812 09-Apr-2025 § 812.35 (6 links)
917. Reference:USA 21 CFR Part 812 09-Apr-2025 § 812.3 (i) (6 links)
918. Reference:USA 21 CFR Part 812 09-Apr-2025 § 812.3 (n) (6 links)
919. Reference:USA 21 CFR Part 812 09-Apr-2025 § 812.3 (p) (6 links)
920. Reference:USA 21 CFR Part 812 09-Apr-2025 § 812.3 (q) (6 links)
921. Reference:USA 21 CFR Part 812 09-Apr-2025 § 812.3 (r) (6 links)
922. Reference:USA 21 CFR Part 812 09-Apr-2025 § 812.3 (s) (6 links)
923. Reference:USA 21 CFR Part 812 09-Apr-2025 § 812.3 (t) (6 links)
924. Reference:USA 21 CFR Part 812 09-Apr-2025 § 812.42 (6 links)
925. Reference:USA 21 CFR Part 812 09-Apr-2025 § 812.7 (c) (6 links)
926. Reference:USA 42 CFR Part 11 09-Apr-2025 § 11.4 (6 links)
927. Reference:USA 42 CFR Part 11 09-Apr-2025 § 11.44 (6 links)
928. Reference:USA 45 CFR Part 160 09-Apr-2025 § 164.530 (6 links)
929. Reference:USA 45 CFR Part 46 09-Apr-2025 Subpart B (6 links)
930. Reference:USA 45 CFR Part 46 09-Apr-2025 Subpart C (6 links)
931. Reference:USA 45 CFR Part 46 09-Apr-2025 § 46.116 (6 links)
932. Reference:USA FDA - HUMAN DRUG CGMP NOTES Volume 8, Number 3 6 (6 links)
933. Reference:USA FDA Guidance for Industry - Computerized Systems Used in Clinical Trials 13-Apr-2015 III (6 links)
934. Reference:USA FDA Guidance for Industry - Electronic Source Data in Clinical Investigations Sep-2013 GLOSSARY OF TERMS (6 links)
935. Reference:USA FDA Guidance for Industry - Electronic Source Data in Clinical Investigations Sep-2013 II (6 links)
936. Reference:USA FDA Guidance for Industry - Oversight of Clinical Investigations — A Risk-Based Approach to Monitoring Aug-2013 IV A. (6 links)
937. Reference:USA FDA Guidance for Industry - Oversight of Clinical Investigations — A Risk-Based Approach to Monitoring Aug-2013 IV A. Adherence (6 links)
938. Reference:USA FDA Guidance for Industry - Oversight of Clinical Investigations — A Risk-Based Approach to Monitoring Aug-2013 IV A. Conduct (6 links)
939. Reference:USA FDA Guidance for Industry - Oversight of Clinical Investigations — A Risk-Based Approach to Monitoring Aug-2013 IV A. Verification (6 links)
940. Reference:USA FDA INFORMATION SHEET - Recruiting Study Subjects, Guidance for Institutional Review Boards and Clinical Investigators Jan-1998 - (6 links)
941. Reference:USA Informed Consent - FDA Guidance for IRBs, Clinical Investigators, and Sponsors Aug-2023 II. Advertising-001 (6 links)
942. Reference:USA Informed Consent - FDA Guidance for IRBs, Clinical Investigators, and Sponsors Aug-2023 II. Advertising-002 (6 links)
943. Reference:USA Informed Consent - FDA Guidance for IRBs, Clinical Investigators, and Sponsors Aug-2023 II. Introduction (6 links)
944. Reference:USA Informed Consent - FDA Guidance for IRBs, Clinical Investigators, and Sponsors Aug-2023 IV. (6 links)
945. Reference:USA Informed Consent - FDA Guidance for IRBs, Clinical Investigators, and Sponsors Aug-2023 V. (6 links)
946. Reference:USA NCI GUIDELINES FOR INVESTIGATORS: ADVERSE EVENT REPORTING REQUIREMENTS FOR DCTD (CTEP AND CIP) INDs AND IDEs 30-Aug-2024 2.1.14. (6 links)
947. Reference:USA NCI GUIDELINES FOR INVESTIGATORS: ADVERSE EVENT REPORTING REQUIREMENTS FOR DCTD (CTEP AND CIP) INDs AND IDEs 30-Aug-2024 2.1.2 (6 links)
948. Reference:USA NCI GUIDELINES FOR INVESTIGATORS: ADVERSE EVENT REPORTING REQUIREMENTS FOR DCTD (CTEP AND CIP) INDs AND IDEs 30-Aug-2024 2.1.21. (6 links)
949. Reference:USA NCI GUIDELINES FOR INVESTIGATORS: ADVERSE EVENT REPORTING REQUIREMENTS FOR DCTD (CTEP AND CIP) INDs AND IDEs 30-Aug-2024 2.1.28 (6 links)
950. Reference:USA NCI GUIDELINES FOR INVESTIGATORS: ADVERSE EVENT REPORTING REQUIREMENTS FOR DCTD (CTEP AND CIP) INDs AND IDEs 30-Aug-2024 2.1.32 - 2.1.34 (6 links)